货号:A174946 同义名: DGAT-1 Inhibitor 4a;(1R,2R)-2-(4'-(3-phenylureido)biphenylcarbonyl)-cyclopentanecarboxylic acid
A 922500(DGAT-1抑制剂4a)是一种强效、选择性和口服生物利用度的甘油二酰基转移酶1(DGAT-1)抑制剂,其对人类和小鼠DGAT-1的IC50值分别为9 nM和22 nM。
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
靶点 |
|
描述 | A-922500 exhibits high selectivity against other acyltransferases, such as DGAT-2, with an IC50 value of 53 μM, and is also selective over its phylogenetic relatives, acyl coenzyme A cholesterol acyltransferase-1 and -2, with an IC50 value of 296 μM[1]. |
Animal study | A 922500 has been shown to decrease serum triglyceride levels across all tested dosages. Notably, a dosage of 3 mg/kg significantly reduced serum triglycerides by 53%. This same dosage also led to a 55% reduction in serum free fatty acid (FFA) concentrations and a 25% decrease in total cholesterol. However, DGAT-1 inhibition did not significantly impact body weight at any tested dosage. While A 922500 did not significantly alter LDL-cholesterol or HDL-cholesterol levels individually, it did significantly improve the serum LDL/HDL-cholesterol ratio at dosages of 0.3 and 3 mg/kg[1]. |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.33mL 0.47mL 0.23mL |
11.67mL 2.33mL 1.17mL |
23.34mL 4.67mL 2.33mL |
CAS号 | 959122-11-3 |
分子式 | C26H24N2O4 |
分子量 | 428.48 |
别名 | DGAT-1 Inhibitor 4a;(1R,2R)-2-(4'-(3-phenylureido)biphenylcarbonyl)-cyclopentanecarboxylic acid;DGAT-1 inhibitor |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Sealed in dry,Store in freezer, under -20°C |
溶解度 |
DMSO: 50 mg/mL(116.69 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |
PO 5% DMSO + 30% PEG400 + 10% tween 80 + water 5 mg/mL clear |